CID 44144383

2-(1,3-thiazol-4-yl)-1h-benzimidazole-5-sulfonamide

Structural Information

Molecular Formula
C10H8N4O2S2
SMILES
C1=CC2=C(C=C1S(=O)(=O)N)NC(=N2)C3=CSC=N3
InChI
InChI=1S/C10H8N4O2S2/c11-18(15,16)6-1-2-7-8(3-6)14-10(13-7)9-4-17-5-12-9/h1-5H,(H,13,14)(H2,11,15,16)
InChIKey
KGMVTZZDGKDTEU-UHFFFAOYSA-N
Compound name
2-(1,3-thiazol-4-yl)-3H-benzimidazole-5-sulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

3
Patents

280.00888 Da
Monoisotopic Mass

1.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 281.01616 159.0
[M+Na]+ 302.99810 172.4
[M-H]- 279.00160 163.2
[M+NH4]+ 298.04270 176.0
[M+K]+ 318.97204 166.3
[M+H-H2O]+ 263.00614 154.0
[M+HCOO]- 325.00708 172.0
[M+CH3COO]- 339.02273 171.4
[M+Na-2H]- 300.98355 161.7
[M]+ 280.00833 162.4
[M]- 280.00943 162.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe